---
title: "Meril GmbH v SWAT Medical AB and another (UPC CoA 635/2024, 12-02-2025)"
description: "A lawyer or European Patent Attorney who is personally a party before the UPC must still be represented by someone else."
url: https://pitch.law/academy/upc-court-of-appeal/upc-coa-635-2024-2025-02-12
lang: en
author: "UPC Case Law by Pitch"
editor: "Bart Lieben"
datePublished: 2026-11-18T10:07:18.905Z
dateModified: 2026-11-18T10:07:18.905Z
---

# Meril GmbH v SWAT Medical AB and another

Order of the UPC Court of Appeal of 12 February 2025, UPC CoA 635/2024.

UPC Case Law by Pitch, edited by [Bart Lieben](https://pitch.law/team/bart-lieben) · Published 18-11-2026

## TL;DR

A lawyer or European Patent Attorney who is personally a party before the UPC must still be represented by someone else. A chair of a company's board cannot represent that company. The Court of Appeal gave both applicants for register access 14 days to instruct an authorised representative and file a Statement of response. The order closes the self-representation route for qualified practitioners and confirms that the Court may examine representation of its own motion at any stage.

## Key holding

Under R 8.1 RoP, lawyers and European Patent Attorneys are not exempt from the duty to be represented when they are themselves parties in proceedings before the UPC. Representation is a point of admissibility involving public policy (due process), which the Court may examine at any time, including of its own motion. A natural person holding a high-level management position in a legal person, such as chair of its board of directors, cannot represent that legal person, even if qualified under Art 48(1) or (2) UPCA.

## Questions decided

1. Can a European Patent Attorney who is a party represent himself before the UPC?
2. May the Court of Appeal examine representation of its own motion at any stage?
3. Can the chair of a company's board represent that company before the UPC?
4. Is an inadmissibility objection raised for the first time late in the appeal admissible?
5. What follows when a party is found to be unrepresented on appeal?

## Case details

- Court: Court of Appeal of the Unified Patent Court, Second Panel
- Panel: Rian Kalden (presiding judge and legally qualified judge); Ingeborg Simonsson (legally qualified judge and judge-rapporteur); Patricia Rombach (legally qualified judge)
- Date: 12-02-2025
- Case number(s): UPC CoA 635/2024, UPC CFI 15/2023
- Parties: Appellant: Meril GmbH (counterclaimant for revocation and defendant in the main infringement proceedings before the Central Division Paris). Respondents: Respondent 1 (name not stated in the published order), a European Patent Attorney, and SWAT Medical AB (applicants for access to the register at first instance).
- Language of the proceedings: English
- Outcome: The Court ordered Respondent 1 and SWAT Medical each to instruct an authorised representative under R 8.1 RoP within 14 days from service of the order, and to lodge a Statement of response within the same period.
- Official text on the court’s website (PDF): https://www.unified-patent-court.org/sites/default/files/files/api_order/1DC63E7565DB8F7704833D73306401C2_en.pdf

## How to cite

Court of Appeal, Meril GmbH v SWAT Medical AB and another, UPC CoA 635/2024, Order of 12 February 2025 (OSCOLA)

## Full summary

Read the full analyses for free — create a free account: https://pitch.law/academy/upc-court-of-appeal/upc-coa-635-2024-2025-02-12

Topics: [Procedure](https://pitch.law/academy/upc-court-of-appeal/topics/procedure)

## In the same case

- [Meril Italy Srl and others v Edwards Lifesciences Corporation, UPC CoA 464/2024, 25-11-2025](https://pitch.law/academy/upc-court-of-appeal/upc-coa-464-2024-2025-11-25): The Court of Appeal upheld EP 3 646 825 as amended by Auxiliary Request II and confirmed that Meril's Myval Octacor heart valve system infringes it.
- [Meril GmbH v Respondent 1 and SWAT Medical AB, UPC CoA 635/2024, 05-05-2025](https://pitch.law/academy/upc-court-of-appeal/upc-coa-635-2024-2025-05-05): The Court of Appeal set aside a Paris Central Division order that had given a European patent attorney and his company access to all pleadings and evidence in a revocation counterclaim.
- [Meril GmbH and others v Edwards Lifesciences Corporation, UPC CoA 166/2025, 18-04-2025](https://pitch.law/academy/upc-court-of-appeal/upc-coa-166-2025-2025-04-18): The Court of Appeal refused Meril's request to suspend the Munich Local Division's infringement decision in favour of Edwards Lifesciences pending Meril's appeal.
- [Meril Life Sciences Pvt. Ltd v Respondent 1 and SWAT Medical AB, UPC CoA 636/2024, 12-02-2025](https://pitch.law/academy/upc-court-of-appeal/upc-coa-636-2024-2025-02-12): A lawyer or European Patent Attorney who is a party before the UPC cannot represent himself and must instruct a separate authorised representative.

## More on procedure

- [PAUSTIAN & PARTNER Patentanwälte mbB v NUC Electronics Europe GmbH and others, UPC CoA 163/2026, 11-11-2026](https://pitch.law/academy/upc-court-of-appeal/upc-coa-163-2026-2026-11-11): The Court of Appeal granted a patent law firm access to the statements of appeal and statements of grounds of appeal in three closed appeals concerning EP 2 028 981.
- [The Walt Disney Company and others v InterDigital VC Holdings, Inc., UPC CoA 133/2026, 05-11-2026](https://pitch.law/academy/upc-court-of-appeal/upc-coa-133-2026-2026-11-05): A request under R 262A RoP to stop the other party from accessing or using confidential information cannot be made for the first time on appeal for material already filed at first instance.
- [Guardant Health, Inc. v Sophia Genetics SA and others, UPC CoA 49/2026, 05-11-2026](https://pitch.law/academy/upc-court-of-appeal/upc-coa-49-2026-2026-11-05): The Court of Appeal set aside a EUR 600,000 award of representation costs because the successful party had backed it only with invoices reading "supply of legal services" and general assertions about complexity and urgency.
